Skoči na glavni sadržaj

Pregledni rad

The new therapeutic options in the treatment of rheumatoid arthritis

Porin PERIĆ ; Klinika za reumatske bolesti i rehabilitaciju Klinički bolnički centar Zagreb, Zagreb


Puni tekst: hrvatski pdf 155 Kb

str. 23-39

preuzimanja: 336

citiraj

Puni tekst: engleski pdf 155 Kb

str. 23-39

preuzimanja: 386

citiraj


Sažetak

Rheumatoid arthritis(RA) is a chronic, inflammatory, autoimmune disease wich affects approximately 1% of world population. Multiple cytokines operate as a network in a redundant and overlapping manner in rheumatoid artrhitis. This review highlights recent data on tumor-necrosis factor alpha (TNF-alfa), interleukin-1 inhibitors, as well as new biological agents abatacept and rituximab wich are specifically targeted
to T cells and to population of B cells.

Ključne riječi

biological agents; rheumatoid arthritis; TNF-alpha inhibitors

Hrčak ID:

129200

URI

https://hrcak.srce.hr/129200

Datum izdavanja:

28.7.2006.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.020 *